Table 3_Autologous regenerative cell therapy for female stress urinary incontinence: a sys

Jiemei Chen published a meta-analysis of 19 clinical studies involving 591 patients on figshare in June 2026. The dataset compiles clinical outcomes for autologous regenerative cell therapy for female stress urinary incontinence. It reports pooled cure and improvement rates, symptom changes, quality of life scores, urodynamic parameters, and adverse events.

Use Cases

• Calculate pooled efficacy rates based on reported cure and improvement outcomes
• Assess treatment safety profiles based on adverse event and loss to follow-up rates
• Analyze symptom improvement based on pad test results, leakage frequency, and questionnaire scores
• Evaluate changes in urodynamic parameters such as post-void residual volume

Strengths

• Includes data from 19 studies and 591 patients, providing a consolidated evidence base
• Reports specific pooled outcomes, including a 41% cure rate and a 55% improvement rate
• Analyzes multiple secondary outcomes including pad tests, leakage frequency, and quality of life scores

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• The description notes significant heterogeneity across all outcome measures and low-to-moderate study quality
• Row count is unknown, which may limit suitability assessment

Provenance

Source

figshare

Collection Method

Systematic review and meta-analysis of studies from PubMed, Web of Science, EMBASE, Cochrane Library, and CINAHL databases.

Freshness

Last updated 2026-06-03 04:47:19; freshness should be verified